The Institute of Healthy Ageing is an interdisciplinary centre of excellence
for research on the biology of ageing and ageing-related diseases. The
biological process of ageing contributes to increased risk of a wide
range of diseases, from neurodegenerative diseases (e.g. Alzheimer's and
Parkinson's disease) and cancer to cardiovascular disease (causing
heart attack and stroke) and age-related macular degeneration (causing
blindness in the elderly).
Our primary purpose is to bring together researchers working on the basic biology of ageing (biogerontology) with those working to understand the causes of ageing-related disease. By merging the two, we aim to develop a new translational biogerontology using the ageing process as a point of intervention to protect against the diseases of old age. Our goal is to improve the health and quality of life for older people.
The work of the Institute of Healthy Ageing is pursuing these ends by:
- Conducting world class research on the biology of ageing and ageing-related disease
- Increasing capacity in research on the biology of ageing by training new researchers and nurturing the work of younger principal investigators
- Teaching about the biology of ageing at undergraduate and postgraduate levels
problem of ageing is not just an issue of biology, but also of social
science, economics and the built environment. A secondary aim of the
Institute is to nurture broader collaborations across UCL between
researchers working on different aspects of ageing.
We aim, through our combined activities, to transform healthcare technology and the social conditions of the elderly to create a future society in which the lives of older people are healthy, meaningful and happy.